Rare diseases
Investigational molecules
Locations
500 Kendall Street, 02142-1108, United States
Takeda Development Center Americas Inc. funds research in ulcerative colitis, Crohn’s disease, chronic pouchitis, and complex perianal fistulas, with additional interest in pediatric and adult disease activity, mucosal healing, and remission outcomes. Its portfolio also includes studies in gastroesophageal reflux disease and erosive esophagitis, extending into pediatric gastrointestinal care.
The sponsor’s gastrointestinal research spans both adult and pediatric populations, including refractory and moderate-to-severe inflammatory disease.
Takeda Development Center Americas Inc. runs clinical trials in conditions such as Crohn's disease, Colitis ulcerative, Narcolepsy, Psoriasis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgium
AustriaBelgium
Germany
France
BulgariaBulgariaBelgiumAustriaAustria
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
